Transcranial Pulse Stimulation (TPS): first NEUROLITH system installed in Switzerland

Transcranial Pulse Stimulation (TPS^®) for the treatment of Alzheimer's patients is now also  available for patients in Switzerland. In early February 2021, the first NEUROLITH^® system was successfully installed in the Praxis Alexander Russ in Zurich. The NEUROLITH^® practice A. Russ has already treated the first patients and reports that TPS^® is in high demand: »We have numerous appointment requests from patients from the greater Zurich area, but also from the entire Lake Constance region and neighbouring southern Germany.« In addition to Switzerland, TPS^® is already available in Germany, Austria, Spain, France, Denmark, Portugal, England, Kuwait, Hong Kong, China and Canada. Another 15 installations are firmly planed until the middle of this year. About TPS^® treatment In 2018, Transcranial Pulse Stimulation (TPS^®) with the NEUROLITH^® system was the first, and hitherto only, procedure of its kind to obtain market authorization for the »treatment of the central nervous system of patients with Alzheimer’s disease«. TPS^® can stimulate deep cerebral regions, reaching as much as 8 cm into the brain. Owing to the short duration of the TPS^® stimulation, tissue heating is avoided. The pulses applied to the treatment area thus develop their maximum clinical effectiveness. TPS^® treatment is performed through the closed skull. In studies, TPS^® treatment has been shown to significantly improve CERAD test performance and to reduce Beck’s depression index in patients with mild to moderate dementia.